Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications

被引：23
|
作者：
Magee, CJ [1 ]
Greenhalf, W [1 ]
Howes, N [1 ]
Ghaneh, P [1 ]
Neoptolemos, JP [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Dept Surg, Liverpool L69 3GA, Merseyside, England
来源：
SURGICAL ONCOLOGY-OXFORD | 2001年 / 10卷 / 1-2期
关键词：
pancreatic cancer; hereditary pancreatitis; pathogenesis; screening; treatment;
D O I：
10.1016/S0960-7404(01)00016-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Pancreatic ductal adenocarcinoma (PDAC) is a significant cause of cancer death worldwide. PDAC is also one of the best-studied cancers with regard to molecular pathogenesis. The chief risk factors associated with PDAC are smoking and pancreatitis, in addition genetic predisposition seems to play a major role. This genetic predisposition may in some cases be indirect, for example via the elevated risk of pancreatitis seen in patients with hereditary pancreatitis (HP). The elucidation of the molecular causes of PDAC has enabled the provision of secondary screening for PDAC in conditions such as HP. This review is concerned with the molecular pathogenesis of PDAC and the application of this basic scientific understanding into state-of-the-art clinical practice. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1 / 23
页数：23
相关论文
共 50 条
  • [1] Molecular pathogenesis of pancreatic adenocarcinoma: Potential clinical implications
    Talar-Wojnarowska, Renata
    Malecka-Panas, Ewa
    MEDICAL SCIENCE MONITOR, 2006, 12 (09): : RA186 - RA193
  • [2] Pathogenesis of the ductal pancreatic adenocarcinoma: Implications for future therapies?
    Schneider, G
    Schmid, R
    INTERNIST, 2005, 46 (02): : 157 - +
  • [3] Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma
    Biankin, AV
    Kench, JG
    Dijkman, FP
    Biankin, SA
    Henshall, SM
    PATHOLOGY, 2003, 35 (01) : 14 - 24
  • [4] Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications
    Angstadt, Shantel
    Zhu, Qingfeng
    Jaffee, Elizabeth M.
    Robinson, Douglas N.
    Anders, Robert A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Clinical implications of biological markers in pancreatic ductal adenocarcinoma
    Giovinazzo, Francesco
    Turri, Giulia
    Zanini, Sara
    Butturini, Giovanni
    Scarpa, Aldo
    Bassi, Claudio
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (04): : E171 - E182
  • [6] Pathology of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications
    Nagaria, Teddy Sutardji
    Wang, Hua
    Chatterjee, Deyali
    Wang, Huamin
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (07) : 838 - 845
  • [7] Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
    Luchini, Claudio
    Brosens, Lodewijk A. A.
    Wood, Laura D.
    Chatterjee, Deyali
    Shin, Jae Il
    Sciammarella, Concetta
    Fiadone, Giulia
    Malleo, Giuseppe
    Salvia, Roberto
    Kryklyva, Valentyna
    Piredda, Maria L.
    Cheng, Liang
    Lawlor, Rita T.
    Adsay, Volkan
    Scarpa, Aldo
    GUT, 2021, 70 (01) : 148 - 156
  • [8] Epidemiology and pathogenesis of pancreatic ductal adenocarcinoma and cholangiocarcinoma
    Goeppert, B.
    Bergmann, F.
    ONKOLOGE, 2015, 21 (11): : 1011 - 1018
  • [9] The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma
    Robinson, Stuart M.
    Fan, Lavender
    White, Steven A.
    Charnley, Richard M.
    Mann, Jelena
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2016, 75 : 131 - 139
  • [10] Update on the Molecular Pathogenesis of Pancreatic Tumors Other than Common Ductal Adenocarcinoma
    Antonello, D.
    Gobbo, S.
    Corbo, V.
    Sipos, B.
    Lemoine, N. R.
    Scarpa, A.
    PANCREATOLOGY, 2009, 9 (1-2) : 25 - 33
12345